WHO ICTRP trial
Prospective evaluation of diabetes/ impaired glucose tolerance and insulin…
JPRN-UMIN000013804 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000013804 |
|---|---|
| Public title | Prospective evaluation of diabetes/ impaired glucose tolerance and insulin resistance among patients with endometrial cancer |
| Scientific title | Prospective evaluation of diabetes/ impaired glucose tolerance and insulin resistance among patients with endometrial cancer - Prospective evaluation of diabetes/ impaired glucose tolerance and insulin resistance among patients with endometrial cancer |
| Primary sponsor | Graduate School of Medicine, Chiba University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Atypical endometrial hyperplasia Endometrial cancer |
| Interventions | All patients, except those with a confirmed diagnosis of DM, underwent the 75-g oral glucose tolerance test |
| Registration date | Apr 25, 2014 |
| Target size | 300 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: